Phase I Study of S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Nedaplatin (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions
- 05 Mar 2012 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 05 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2010 New trial record